SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-23-000276
Filing Date
2023-06-15
Accepted
2023-06-15 10:19:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2798
  Complete submission text file 0001971857-23-000276.txt   4191
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-23186 | Film No.: 231016228
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NOVAN, INC. 4105 HOPSON ROAD MORRISVILLE NC 27560
Business Address
SANDERS MACHELLE (Reporting) CIK: 0001718020 (see all company filings)

Type: 144